Delay From Hypotension Onset to Appropriate Antifungal Therapy Initiation Is the Critical Determinant of Outcome in Candida Septic Shock.
文献摘要
Objectives To determine the effect of delays in initiation of appropriate antifungal therapy from the initial onset of persistent hypotension to the outcome of Candida septic shock. Design Retrospective cohort study. Setting A total of 32 academic and community hospitals in Canada, the United States, and Saudi Arabia (July 1989 to June 2018). Patients A total of 850 adult patients with culture-positive Candida septic shock. Interventions None. Measurements and main results Out of 850 patients with Candida septic shock, 69.2% patients (589) received appropriate antifungal therapy after the onset of persistent hypotension. A strong relationship was observed between the delay in initiation of pathogen-appropriate antifungal (PAA) therapy and hospital survival. The adjusted odds ratio of death was 1.045 per hour of delay (95% CI, 1.035-1.056; p Conclusions Administration of PAAs within the first hours of documented hypotension significantly improved hospital survival. Less than 20% of patients received appropriate antifungals within 6 hours of documented hypotension.